KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism
Abstract Background Lysine acetylation is a critical post-translational modification regulating tumor initiation and progression. Lysine acetyltransferase 7 (KAT7)-mediated lysine acetylation is frequently dysregulated in cancer. However, the role of KAT7-mediated lysine acetylation in hepatocellula...
Saved in:
| Main Authors: | He Huang, Longfei Ren, Yongqiang Zhou, Pengyu Chen, Haixia Zhao, Shang Li, Haiping Wang, Xun Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-13708-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A
by: Roberta Pacifico, et al.
Published: (2022-12-01) -
METTL14-mediated miR-122-5p maturation stimulated tumor progression by targeting KAT2A in hepatocellular carcinoma
by: Xiangyu Fan, et al.
Published: (2025-05-01) -
KAT6A chimeras form a self-reinforcing epigenetic module with NURF and MLL/COMPASS to sustain AML
by: Junhui Lv, et al.
Published: (2025-08-01) -
YBX1: an RNA/DNA-binding protein that affects disease progression
by: Xifeng Zheng, et al.
Published: (2025-07-01) -
Targeting YBX1‐m5C mediates RNF115 mRNA circularisation and translation to enhance vulnerability of ferroptosis in hepatocellular carcinoma
by: Ouwen Li, et al.
Published: (2025-03-01)